A detailed history of Parkside Financial Bank & Trust transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 1,201 shares of EW stock, worth $78,641. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,201
Previous 1,094 9.78%
Holding current value
$78,641
Previous $104,000 5.77%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$84.3 - $94.31 $9,020 - $10,091
107 Added 9.78%
1,201 $110,000
Q1 2024

May 01, 2024

SELL
$72.54 - $95.56 $2,248 - $2,962
-31 Reduced 2.76%
1,094 $104,000
Q4 2023

Feb 01, 2024

BUY
$61.71 - $77.76 $10,120 - $12,752
164 Added 17.07%
1,125 $85,000
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $14,479 - $19,516
-209 Reduced 17.86%
961 $66,000
Q2 2023

Aug 15, 2023

BUY
$81.41 - $94.33 $2,198 - $2,546
27 Added 2.36%
1,170 $110,000
Q1 2023

May 04, 2023

BUY
$74.26 - $84.51 $7,351 - $8,366
99 Added 9.48%
1,143 $94,000
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $3,415 - $4,372
50 Added 5.03%
1,044 $77,000
Q3 2022

Nov 01, 2022

BUY
$82.37 - $107.29 $3,624 - $4,720
44 Added 4.63%
994 $82,000
Q2 2022

Jul 13, 2022

SELL
$86.5 - $128.27 $173 - $256
-2 Reduced 0.21%
950 $90,000
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $8,768 - $11,037
86 Added 9.93%
952 $112,000
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $17,657 - $21,692
166 Added 23.71%
866 $112,000
Q3 2021

Oct 29, 2021

BUY
$102.91 - $122.75 $8,644 - $10,311
84 Added 13.64%
700 $79,000
Q2 2021

Aug 06, 2021

BUY
$83.84 - $104.76 $1,592 - $1,990
19 Added 3.18%
616 $64,000
Q1 2021

May 10, 2021

BUY
$78.68 - $90.67 $1,416 - $1,632
18 Added 3.11%
597 $50,000
Q4 2020

Feb 09, 2021

BUY
$71.69 - $91.23 $1,147 - $1,459
16 Added 2.84%
579 $53,000
Q3 2020

Nov 06, 2020

SELL
$67.19 - $87.44 $67 - $87
-1 Reduced 0.18%
563 $45,000
Q2 2020

Aug 10, 2020

BUY
$57.54 - $76.95 $22,383 - $29,933
389 Added 222.29%
564 $39,000
Q1 2020

May 05, 2020

SELL
$52.41 - $81.0 $3,459 - $5,346
-66 Reduced 27.39%
175 $33,000
Q4 2019

Jan 30, 2020

SELL
$71.7 - $82.09 $645 - $738
-9 Reduced 3.6%
241 $56,000
Q2 2019

Aug 06, 2019

BUY
$55.74 - $64.41 $167 - $193
3 Added 1.21%
250 $46,000
Q1 2019

May 01, 2019

BUY
$47.89 - $64.05 $4,501 - $6,020
94 Added 61.44%
247 $47,000
Q4 2018

Jan 31, 2019

BUY
$46.41 - $56.94 $2,413 - $2,960
52 Added 51.49%
153 $23,000
Q3 2018

Oct 12, 2018

SELL
$45.7 - $58.03 $91 - $116
-2 Reduced 1.94%
101 $17,000
Q2 2018

Aug 03, 2018

BUY
$42.45 - $51.3 $382 - $461
9 Added 9.57%
103 $15,000
Q1 2018

May 02, 2018

BUY
$37.19 - $47.45 $892 - $1,138
24 Added 34.29%
94 $13,000
Q4 2017

Feb 05, 2018

SELL
$33.79 - $39.39 $4,291 - $5,002
-127 Reduced 64.47%
70 $8,000
Q3 2017

Oct 27, 2017

BUY
$36.29 - $38.83 $7,149 - $7,649
197
197 $22,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.